Y Shimada, S Okuda, Y Watanabe… - Journal of …, 2021 - kyushu-u.elsevierpure.com
Background: Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …